Caroline Catherman

Wondering who’s in and who’s out at major startups, health companies, and hospitals? We’ve got you covered.

No ACA? No problem, says the American Farm Bureau Federation.

Robert F. Kennedy Jr. has been a prominent critic of childhood vaccinations and the Covid-19 vaccine.

Medicare Part D’s transformation continues.

Insurance executives and experts told Healthcare Brew the biggest lessons learned from a year full of surprises.

Payers are planning for rising drug costs, continuous Medicare Advantage shake-ups, and a new US president.

On November 25, Cassava Sciences ended a Phase 3 trial of its controversial Alzheimer’s drug, simufilam, following years of scrutiny.

Genomic testing could diagnose rare diseases within weeks, but misconceptions are slowing progress, GeneDx CEO says.

It’s a tough time to run an abortion clinic.

Documents show pharmacy benefit managers helped drugmakers like Purdue Pharma dole out opioids in exchange for payouts.